ModernPathology这几年的影响因子有所起伏，2021年8.209分，预测今年会有所回落至7.85左右。2022年中科院最新分区：1区top，是本值得投资的期刊。
期刊影响因子排名↓↓↓
6/77病理学
按期刊引文指标(JCI)排名↓↓↓
3/89病理学
JCR分区
中科院分区
发文情况
收稿范围
社论
版面费
审稿周期
以下为近期官网发表的Articles实例：
1.从收到稿件到接受稿件用时：112天PD-L1andPD-1expressioninpediatriccentralnervoussystemgermcelltumors
2.从收到稿件到接受稿件用时：183天Validityofatwo-antibodytestingalgorithmformismatchrepairdeficiencytestingincancer;asystematicliteraturereviewandmeta-analysis
3.从收到稿件到接受稿件用时：70天Genderdistributionofeditorsandauthorsofreferencetextbooksinanatomicpathology:furthereditsarerequired
4.从收到稿件到接受稿件用时：128天Artificialintelligence-augmentedhistopathologicreviewusingimageanalysistooptimizeDNAyieldfromformalin-fixedparaffin-embeddedslides
5.从收到稿件到接受稿件用时：142天ERBB2mutationisassociatedwithsustainedtumorcellproliferationaftershort-termpreoperativeendocrinetherapyinearlylobularbreastcancer
6.从收到稿件到接受稿件用时：76天Resultsofaworldwidesurveyonthecurrentlyusedhistopathologicaldiagnosticcriteriaforinvasivelobularbreastcancer
7.从收到稿件到接受稿件用时：100天PrimarycutaneousSMARCA4-deficientundifferentiatedmalignantneoplasm:firsttwocaseswithclinicopathologicandmolecularcomparisontoeightvisceralcounterparts
8.从收到稿件到接受稿件用时：180天RB1-deficientsquamouscellcarcinoma:theproposedsourceofcombinedMerkelcellcarcinoma